NCT01665768 2021-10-26Maintenance Rituximab With mTor Inhibition After High-dose Consolidative Therapy in LymphomaSidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 2 Completed56 enrolled 10 charts